National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 51644-51645 [07-4394]
Download as PDF
<![CDATA[
51644
Federal Register / Vol. 72, No. 174 / Monday, September 10, 2007 / Notices
Contact Person: Sooyoun (Sonia) Kim, MS,
45 Center Dr., 4An 32B, Division of
Extramural Research, National Inst. of Dental
& Craniofacial Research, National Institute of
Health, Bethesda, MD 20892, (301) 594–4827,
kims@mail.nidr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, Review R21.
Date: October 31, 2007.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Sooyoun (Sonia) Kim, MS,
45 Center Dr., 4An 32B, Division of
Extramural Research, National Inst. of Dental
& Craniofacial Research, National Institute of
Health, Bethesda, MD 20892, (301) 594–4827,
kims@mail.nidr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
ebenthall on PRODPC61 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Prion Transmission and
Detection.
Date: October 3, 2007.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
15:27 Sep 07, 2007
Jkt 211001
Dated: August 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4391 Filed 9–7–07; 8:45 am]
BILLING CODE 4140–01–M
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call)
Contact Person: D. G. Patel, PhD, Scientific
Review Administrator, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
914, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 30, 2007.
Jennifer Spaeth,
Director, Office of Advisory Committee Policy.
[FR Doc. 07–4392 Filed 9–7–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Dated: August 29, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4390 Filed 9–7–07; 8:45 am]
VerDate Aug<31>2005
3253, Bethesda, MD 20817. (Telephone
Conference Call).
Contact Person: Darren D. Sledjeski, PhD,
Scientific Review Administrator, NIH/NIAID/
DHHS, Scientific Review Program, 6700B
Rockledge Drive, MSC–7616, Room 3131,
Bethesda, MD 20892–7616, 301–451–2638,
sledjeskid@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Translational
Research.
Date: October 25, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Michele L. Barnard, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8898, barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, ZDK1 GRB–N J2.
Date: November 16, 2007.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Division of Intramural Research Board
of Scientific Counselors, NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: December 3–5, 2007.
Time: December 3, 2007, 8 a.m. to 6:50
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Time: December 4, 2007, 8 a.m. to 5:50
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
E:\FR\FM\10SEN1.SGM
10SEN1
Federal Register / Vol. 72, No. 174 / Monday, September 10, 2007 / Notices
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Time: December 5, 2007, 8 a.m. to 12 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Contact Person: Kathryn C. Zoon, PhD,
Director, Division of Intramural Research,
National Institute of Allergy and Infectious
Diseases, NIH, Building 31, Room 4A30,
Bethesda, MD 20892, 301–496–3006,
kzoon@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4394 Filed 9–07–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
ebenthall on PRODPC61 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Special
Grants Review Committee.
Date: October 25–26, 2007.
Time: 8 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott Courtyard,
Washingtonian Center, 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Helen Lin, PhD, Scientific
Review Administrator, NIH/NIAMS/RB, 6701
Democracy Blvd., Suite 800, Plaza One,
Bethesda, MD 20817, 301–594–4952,
linh1@mail.nih.gov.
VerDate Aug<31>2005
15:27 Sep 07, 2007
Jkt 211001
Dated: August 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4399 Filed 9–7–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Advisory Neurological
Disorders and Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plans to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodation, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Training, Career Development, and Special
Programs Subcommittee.
Date: September 19, 2007.
Open: 8 p.m. to 9:45 p.m.
Agenda: To discuss the training programs
of the Institute.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Closed: 9:45 p.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Stephen J. Korn, PhD.,
Training and Special Programs Officer,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2154, MSC 9527,
Bethesda, MD 20892–9527, (301) 496–4188.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Basic and Preclinical Programs
Subcommittee.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
51645
Date: September 20, 2007.
Closed: 8 a.m. to 8:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, A Wing, 31 Center Drive,
Conference Room 8A–28, Bethesda, MD
20892
Open: 8:30 a.m. to 10 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, A Wing, 31 Center Drive,
Conference Room 8A–28, Bethesda, MD
20892.
Contact Person: Robert Baughman, MD,
Associate Director for Technology
Development, National Institute of
Neurological Disorders and Stroke, National
Institutes of Health, 6001 Executive Blvd.,
Suite 2137, MSC 9527, Bethesda, MD 20892–
9527, (301) 496–1779.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Clinical Trials Subcommittee.
Date: September 20, 2007.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Open: 9 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, C Wing, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Contact Person: John Marler, MD,
Associate Director for Clinical Trials,
National Institute of Neurological, Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2216, Bethesda,
MD 20892, (301) 496–9135, jm137f@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: August 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4400 Filed 9–7–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\10SEN1.SGM
10SEN1
]]>Agencies
[Federal Register Volume 72, Number 174 (Monday, September 10, 2007)]
[Notices]
[Pages 51644-51645]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4394]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Division of Intramural Research Board of Scientific Counselors,
NIAID.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Allergy and Infectious Diseases, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Division of Intramural Research Board of
Scientific Counselors, NIAID.
Date: December 3-5, 2007.
Time: December 3, 2007, 8 a.m. to 6:50 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, 50 Center
Drive, Conference Rooms 1227/1233, Bethesda, MD 20892.
Time: December 4, 2007, 8 a.m. to 5:50 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
[[Page 51645]]
Place: National Institutes of Health, Building 50, 50 Center
Drive, Conference Rooms 1227/1233, Bethesda, MD 20892.
Time: December 5, 2007, 8 a.m. to 12 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, 50 Center
Drive, Conference Rooms 1227/1233, Bethesda, MD 20892.
Contact Person: Kathryn C. Zoon, PhD, Director, Division of
Intramural Research, National Institute of Allergy and Infectious
Diseases, NIH, Building 31, Room 4A30, Bethesda, MD 20892, 301-496-
3006, kzoon@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4394 Filed 9-07-07; 8:45 am]
BILLING CODE 4140-01-M
